NO20052479L - Tramadolformuleringer med forsinket frigjoring og 24 timers effektivitet - Google Patents
Tramadolformuleringer med forsinket frigjoring og 24 timers effektivitetInfo
- Publication number
- NO20052479L NO20052479L NO20052479A NO20052479A NO20052479L NO 20052479 L NO20052479 L NO 20052479L NO 20052479 A NO20052479 A NO 20052479A NO 20052479 A NO20052479 A NO 20052479A NO 20052479 L NO20052479 L NO 20052479L
- Authority
- NO
- Norway
- Prior art keywords
- delayed release
- release tramadol
- tramadol formulations
- hour efficacy
- efficacy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28102602A | 2002-10-25 | 2002-10-25 | |
US51037803P | 2003-10-10 | 2003-10-10 | |
PCT/CA2003/001638 WO2004037222A2 (en) | 2002-10-25 | 2003-10-27 | Sustained-release tramadol formulations with 24-hour efficacy |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20052479D0 NO20052479D0 (no) | 2005-05-23 |
NO20052479L true NO20052479L (no) | 2005-05-23 |
Family
ID=32179487
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20052479A NO20052479L (no) | 2002-10-25 | 2005-05-23 | Tramadolformuleringer med forsinket frigjoring og 24 timers effektivitet |
Country Status (11)
Country | Link |
---|---|
JP (1) | JP2006507277A (ru) |
KR (1) | KR20050083816A (ru) |
AR (1) | AR045972A1 (ru) |
AU (1) | AU2003275855B2 (ru) |
CA (1) | CA2503155A1 (ru) |
IL (1) | IL168114A (ru) |
NO (1) | NO20052479L (ru) |
PT (1) | PT1594460E (ru) |
RU (1) | RU2328275C2 (ru) |
UA (1) | UA84277C2 (ru) |
WO (1) | WO2004037222A2 (ru) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
TWI319713B (en) | 2002-10-25 | 2010-01-21 | Sustained-release tramadol formulations with 24-hour efficacy | |
US8487002B2 (en) | 2002-10-25 | 2013-07-16 | Paladin Labs Inc. | Controlled-release compositions |
EP1905435A3 (en) * | 2003-03-11 | 2008-05-14 | Euro-Celtique S.A. | Titration dosing regimen for controlled release tramadol |
US7413749B2 (en) * | 2003-03-11 | 2008-08-19 | Purdue Pharma L.P. | Titration dosing regimen for controlled release tramadol |
DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
MXPA06013270A (es) * | 2004-05-14 | 2007-04-23 | Johnson & Johnson | Compuestos de opioide carboxamido. |
DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
CA2616416A1 (en) * | 2005-09-09 | 2007-05-03 | Labopharm, Inc. | Trazodone composition for once a day adminisitiation |
PL2010158T3 (pl) * | 2006-04-26 | 2016-09-30 | Formulacje o kontrolowanym uwalnianiu zawierające niepowlekaną odrębną jednostkę(-i) i macierz o przedłużonym uwalnianiu | |
CA2713128C (en) | 2008-01-25 | 2016-04-05 | Gruenenthal Gmbh | Pharmaceutical dosage form |
KR101690094B1 (ko) | 2008-05-09 | 2016-12-27 | 그뤼넨탈 게엠베하 | 분무 응결 단계의 사용하에 중간 분말 제형 및 최종 고체 제형을 제조하는 방법 |
US8642631B2 (en) | 2008-05-27 | 2014-02-04 | University Of Melbourne | Methods of treating mammals with eustachian tube dysfunctions |
KR20110119845A (ko) * | 2008-10-27 | 2011-11-02 | 알자 코퍼레이션 | 지속 방출형 경구용 아세트아미노펜/트라마돌 제형 |
NZ596667A (en) | 2009-07-22 | 2013-09-27 | Gruenenthal Chemie | Hot-melt extruded controlled release dosage form |
BR112012001466A2 (pt) | 2009-07-22 | 2020-08-11 | Grünenthal GmbH | forma de dosagem resistente à falsificação para opioides sensíveis à oxidação, seu processo de fabricação, e embalagem |
US9579285B2 (en) | 2010-02-03 | 2017-02-28 | Gruenenthal Gmbh | Preparation of a powdery pharmaceutical composition by means of an extruder |
CA2808219C (en) | 2010-09-02 | 2019-05-14 | Gruenenthal Gmbh | Tamper resistant dosage form comprising inorganic salt |
PE20131126A1 (es) | 2010-09-02 | 2013-10-21 | Gruenenthal Chemie | Forma de dosificacion resistente a alteracion que comprende un polimero anionico |
CA2839123A1 (en) | 2011-07-29 | 2013-02-07 | Grunenthal Gmbh | Tamper-resistant tablet providing immediate drug release |
MX348054B (es) | 2011-07-29 | 2017-05-25 | Gruenenthal Gmbh | Tableta a prueba de alteracion que proporciona liberacion inmediata del farmaco. |
EP2819656A1 (en) | 2012-02-28 | 2015-01-07 | Grünenthal GmbH | Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer |
SI2838512T1 (sl) | 2012-04-18 | 2018-11-30 | Gruenenthal Gmbh | Pred posegi in prehitrim sproščanjem odporna farmacevtska oblika odmerka |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
US10154966B2 (en) | 2013-05-29 | 2018-12-18 | Grünenthal GmbH | Tamper-resistant dosage form containing one or more particles |
CA2913209A1 (en) | 2013-05-29 | 2014-12-04 | Grunenthal Gmbh | Tamper resistant dosage form with bimodal release profile |
KR20160031526A (ko) | 2013-07-12 | 2016-03-22 | 그뤼넨탈 게엠베하 | 에틸렌-비닐 아세테이트 중합체를 함유하는 템퍼 내성 투여형 |
BR112016010482B1 (pt) | 2013-11-26 | 2022-11-16 | Grünenthal GmbH | Preparação de uma composição farmacêutica em pó por meio de criomoagem |
CN106572980A (zh) | 2014-05-12 | 2017-04-19 | 格吕伦塔尔有限公司 | 包含他喷他多的防篡改即释胶囊制剂 |
EP3148512A1 (en) | 2014-05-26 | 2017-04-05 | Grünenthal GmbH | Multiparticles safeguarded against ethanolic dose-dumping |
CA2983642A1 (en) | 2015-04-24 | 2016-10-27 | Grunenthal Gmbh | Tamper-resistant dosage form with immediate release and resistance against solvent extraction |
US10842750B2 (en) | 2015-09-10 | 2020-11-24 | Grünenthal GmbH | Protecting oral overdose with abuse deterrent immediate release formulations |
CN109310646A (zh) | 2016-05-05 | 2019-02-05 | 阿奎斯蒂弗医疗股份有限公司 | 增强递送的肾上腺素组合物 |
US20170290776A1 (en) * | 2016-05-05 | 2017-10-12 | Monosol Rx, Llc | Pharmaceutical compositions with enhanced permeation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL119660A (en) * | 1993-05-10 | 2002-09-12 | Euro Celtique Sa | Controlled release formulation comprising tramadol |
DE19530575A1 (de) * | 1995-08-19 | 1997-02-20 | Gruenenthal Gmbh | Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz |
ES2263211T3 (es) * | 1997-07-02 | 2006-12-01 | Euro-Celtique S.A. | Formulaciones de tramadol de liberacion sostenida estabilizada. |
DE10015479A1 (de) * | 2000-03-29 | 2001-10-11 | Basf Ag | Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität |
US6607748B1 (en) * | 2000-06-29 | 2003-08-19 | Vincent Lenaerts | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
DE10108122A1 (de) * | 2001-02-21 | 2002-10-02 | Gruenenthal Gmbh | Arzneimittel auf Basis von Tramadol |
-
2003
- 2003-10-27 RU RU2005115855/15A patent/RU2328275C2/ru not_active IP Right Cessation
- 2003-10-27 PT PT03809237T patent/PT1594460E/pt unknown
- 2003-10-27 AU AU2003275855A patent/AU2003275855B2/en not_active Expired
- 2003-10-27 KR KR1020057007089A patent/KR20050083816A/ko not_active Application Discontinuation
- 2003-10-27 AR ARP030103926A patent/AR045972A1/es unknown
- 2003-10-27 WO PCT/CA2003/001638 patent/WO2004037222A2/en active IP Right Grant
- 2003-10-27 UA UAA200504852A patent/UA84277C2/ru unknown
- 2003-10-27 JP JP2004545655A patent/JP2006507277A/ja active Pending
- 2003-10-27 CA CA002503155A patent/CA2503155A1/en not_active Abandoned
-
2005
- 2005-04-19 IL IL168114A patent/IL168114A/en active IP Right Grant
- 2005-05-23 NO NO20052479A patent/NO20052479L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
UA84277C2 (ru) | 2008-10-10 |
JP2006507277A (ja) | 2006-03-02 |
AU2003275855A1 (en) | 2004-05-13 |
CA2503155A1 (en) | 2004-05-06 |
KR20050083816A (ko) | 2005-08-26 |
AU2003275855B2 (en) | 2009-04-23 |
RU2328275C2 (ru) | 2008-07-10 |
NO20052479D0 (no) | 2005-05-23 |
RU2005115855A (ru) | 2006-01-20 |
AR045972A1 (es) | 2005-11-23 |
WO2004037222A3 (en) | 2005-09-22 |
WO2004037222A2 (en) | 2004-05-06 |
PT1594460E (pt) | 2008-06-27 |
IL168114A (en) | 2011-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20052479L (no) | Tramadolformuleringer med forsinket frigjoring og 24 timers effektivitet | |
NO20050379L (no) | Anvendelse av venlafaxinhydroklorid for fremstilling av en innkapslet forlenget frigjoringsblanding | |
HK1101355A1 (en) | Sustained-release tramadol formulations with 24-hour efficacy 24 | |
NO20080827L (no) | Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon | |
EA200800783A1 (ru) | Композиция тразодона для введения один раз в день | |
IL165264A (en) | Protein kinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating protein kinase-associated diseases | |
NO20080164L (no) | N-(pyridin-2-yl)-sulfonamidderivater | |
NO20065638L (no) | Formuleringer med kontrollert frigivelse inneholdende vardenafil | |
CY1105120T1 (el) | Η αντιμετωπιση αναπνευστικων νοσων | |
BR0306870A (pt) | Composição farmacêutica oral, e, método para preparar a mesma | |
MXPA04009977A (es) | Formulaciones de tramadol de liberacion sostenida con eficacia clinica durante 24 horas. | |
NO20051389L (no) | Stabilisert farmasoytisk blanding inneholdende basiske hjelpemidler | |
HK1062677A1 (en) | 17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
NO20050771L (no) | Bicifadinformulering | |
UA84266C2 (ru) | Дозированная врачебная форма в виде таблетки или гранулы для перорального введения, которая содержит ингибитор pde 4 и поливинилпиролидон, способы ее получения и применения | |
DK1487829T3 (da) | Thiadizolylpiperazinderivater, der er nyttige til behandling eller forebyggelse af smerte | |
NO20062513L (no) | Sammensetninger og doseringsformer for forsterket absorpsjon av metformin | |
NO20042161L (no) | Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1 | |
NO20045486L (no) | Nye forbindelser og deres anvendelse | |
NO20073405L (no) | Farmasoytisk utforming inneholdende en frigjoringshastighetskontrollerende sammensetning | |
DK1572153T3 (da) | Fremstilling af sterile vandige suspensioner, som omfatter mikroniserede krystallinske virksomme stoffer til inhalering | |
NO304113B1 (no) | Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament | |
NO20101070L (no) | Fremgangsmate til dosering av et medikament, samt doseringsform | |
TW200626141A (en) | Crystalline form of a drug | |
DK1228758T3 (da) | Anvendelse af sulfodehydroabietinsyre til behandling af inflammatorisk tarmsygdom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |